Tage Honore SEC EDGAR Filings (CIK 0001967946)

SEC EDGAR filings, ownership reports, and insider transactions for Tage Honore.

Business address
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300 E, Washington, DC, 20037
Top holdings (ownership)
VNDA
Get insider transactions for this reporting owner
Tage Honore has filed 5 SEC EDGAR filings since 17 Mar 2023

Latest Filings

Recent SEC filings for Tage Honore including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 09 Jun 2025 05 Jun 2025 001-34186
4 Open 4 document View SEC filing for 4 4 21 May 2024 17 May 2024 001-34186
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Jun 2023 08 Jun 2023 001-34186
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Mar 2023 15 Mar 2023 001-34186
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 17 Mar 2023 15 Mar 2023 001-34186

About this filer

Tage Honore files with the SEC under CIK 0001967946. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages